Skin anti-aging strategies

Ruta Ganceviciene, Aikaterini I Liakou, Athanasios Theodoridis, Evgenia Makrantonaki, Christos C Zouboulis, Ruta Ganceviciene, Aikaterini I Liakou, Athanasios Theodoridis, Evgenia Makrantonaki, Christos C Zouboulis

Abstract

Skin aging is a complex biological process influenced by a combination of endogenous or intrinsic and exogenous or extrinsic factors. Because of the fact that skin health and beauty is considered one of the principal factors representing overall "well-being" and the perception of "health" in humans, several anti-aging strategies have been developed during the last years. It is the intention of this article to review the most important anti-aging strategies that dermatologists have nowadays in hand, including including preventive measurements, cosmetological strategies, topical and systemic therapeutic agents and invasive procedures.

Keywords: aging; anti-aging; antioxidants; botulinum toxin; cell regulators; fillers; hormone replacement therapy; laser; peeling; prevention.

Figures

https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3583892/bin/de-4-308-g1.jpg
Figure 1. 45-y-old female with signs of photoaged skin: dyschromia of the skin, multiple lentigines. (A) before, (B) after one treatment with IPL with 550 nm cut-off filter.
https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3583892/bin/de-4-308-g2.jpg
Figure 2. Patient showing the difference of the nasolabial fold: non-treated left side (with site marks for planned HA injection) and right side straight after injection of only 0.5 ml of nonanimal stabilized cross-linked HA (“Stalagmite” technique on the right cheek).
https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3583892/bin/de-4-308-g3.jpg
Figure 3. Patient showing glabellar and crow’s feet wrinkles. (A) pre-injection, (B) after injection with botulinum toxin.

References

    1. Cevenini E, Invidia L, Lescai F, Salvioli S, Tieri P, Castellani G, et al. Human models of aging and longevity. Expert Opin Biol Ther. 2008;8:1393–405. doi: 10.1517/14712598.8.9.1393.
    1. Uitto J. Understanding premature skin aging. N Engl J Med. 1997;337:1463–5. doi: 10.1056/NEJM199711133372011.
    1. Scaffidi P, Misteli T. Lamin A-dependent nuclear defects in human aging. Science. 2006;312:1059–63. doi: 10.1126/science.1127168.
    1. Fisher, G.J. The pathophysiology of photoaging of the skin. Cutis, 75, 5–9 (2005)58–69.
    1. Schmuth M, Watson RE, Deplewski D, Dubrac S, Zouboulis CC, Griffiths CE. Nuclear hormone receptors in human skin. Horm Metab Res. 2007;39:96–105. doi: 10.1055/s-2007-961808.
    1. Reichrath J, Lehmann B, Carlberg C, Varani J, Zouboulis CC. Vitamins as hormones. Horm Metab Res. 2007;39:71–84. doi: 10.1055/s-2007-958715.
    1. Verdier-Sévrain S, Bonté F, Gilchrest B. Biology of estrogens in skin: implications for skin aging. Exp Dermatol. 2006;15:83–94. doi: 10.1111/j.1600-0625.2005.00377.x.
    1. Hall G, Phillips TJ. Estrogen and skin: the effects of estrogen, menopause, and hormone replacement therapy on the skin. J Am Acad Dermatol. 2005;53:555–68, quiz 569-72. doi: 10.1016/j.jaad.2004.08.039.
    1. Brincat MP, Baron YM, Galea R. Estrogens and the skin. Climacteric. 2005;8:110–23. doi: 10.1080/13697130500118100.
    1. Draelos ZD. Topical and oral estrogens revisited for antiaging purposes. Fertil Steril. 2005;84:291–2, discussion 295. doi: 10.1016/j.fertnstert.2005.03.033.
    1. Kanda N, Watanabe S. Regulatory roles of sex hormones in cutaneous biology and immunology. J Dermatol Sci. 2005;38:1–7. doi: 10.1016/j.jdermsci.2004.10.011.
    1. Shin MH, Rhie GE, Park CH, Kim KH, Cho KH, Eun HC, et al. Modulation of collagen metabolism by the topical application of dehydroepiandrosterone to human skin. J Invest Dermatol. 2005;124:315–23. doi: 10.1111/j.0022-202X.2004.23588.x.
    1. Kligman LH. Photoaging. Manifestations, prevention, and treatment. Clin Geriatr Med. 1989;5:235–51.
    1. El-Domyati M, Attia S, Saleh F, Brown D, Birk DE, Gasparro F, et al. Intrinsic aging vs. photoaging: a comparative histopathological, immunohistochemical, and ultrastructural study of skin. Exp Dermatol. 2002;11:398–405. doi: 10.1034/j.1600-0625.2002.110502.x.
    1. Moragas A, Castells C, Sans M. Mathematical morphologic analysis of aging-related epidermal changes. Anal Quant Cytol Histol. 1993;15:75–82.
    1. Lock-Andersen J, Therkildsen P, de Fine Olivarius F, Gniadecka M, Dahlstrøm K, Poulsen T, et al. Epidermal thickness, skin pigmentation and constitutive photosensitivity. Photodermatol Photoimmunol Photomed. 1997;13:153–8. doi: 10.1111/j.1600-0781.1997.tb00220.x.
    1. Makrantonaki E, Zouboulis CC. William J. Cunliffe Scientific Awards. Characteristics and pathomechanisms of endogenously aged skin. Dermatology. 2007;214:352–60. doi: 10.1159/000100890.
    1. Makrantonaki E, Zouboulis CC. Molecular mechanisms of skin aging: state of the art. Ann N Y Acad Sci. 2007;1119:40–50. doi: 10.1196/annals.1404.027.
    1. Escoffier C, de Rigal J, Rochefort A, Vasselet R, Lévêque JL, Agache PG. Age-related mechanical properties of human skin: an in vivo study. J Invest Dermatol. 1989;93:353–7. doi: 10.1111/1523-1747.ep12280259.
    1. Yaar M, Gilchrest BA. Aging of skin. In Fitzpatrick’s Dermatology in General Medicine Vol 2, 5th edn. McGraw-Hill:New York, 1999; 1697–1706.
    1. Baumann L. Skin ageing and its treatment. J Pathol. 2007;211:241–51. doi: 10.1002/path.2098.
    1. Watson RE, Craven NM, Kang S, Jones CJ, Kielty CM, Griffiths CE. A short-term screening protocol, using fibrillin-1 as a reporter molecule, for photoaging repair agents. J Invest Dermatol. 2001;116:672–8. doi: 10.1046/j.1523-1747.2001.01322.x.
    1. Contet-Audonneau JL, Jeanmaire C, Pauly G. A histological study of human wrinkle structures: comparison between sun-exposed areas of the face, with or without wrinkles, and sun-protected areas. Br J Dermatol. 1999;140:1038–47. doi: 10.1046/j.1365-2133.1999.02901.x.
    1. Varani J, Spearman D, Perone P, Fligiel SE, Datta SC, Wang ZQ, et al. Inhibition of type I procollagen synthesis by damaged collagen in photoaged skin and by collagenase-degraded collagen in vitro. Am J Pathol. 2001;158:931–42. doi: 10.1016/S0002-9440(10)64040-0.
    1. Brenneisen P, Oh J, Wlaschek M, Wenk J, Briviba K, Hommel C, et al. Ultraviolet B wavelength dependence for the regulation of two major matrix-metalloproteinases and their inhibitor TIMP-1 in human dermal fibroblasts. Photochem Photobiol. 1996;64:877–85. doi: 10.1111/j.1751-1097.1996.tb01851.x.
    1. Fisher GJ, Datta SC, Talwar HS, Wang ZQ, Varani J, Kang S, et al. Molecular basis of sun-induced premature skin ageing and retinoid antagonism. Nature. 1996;379:335–9. doi: 10.1038/379335a0.
    1. Fisher GJ, Wang ZQ, Datta SC, Varani J, Kang S, Voorhees JJ. Pathophysiology of premature skin aging induced by ultraviolet light. N Engl J Med. 1997;337:1419–28. doi: 10.1056/NEJM199711133372003.
    1. Scharffetter-Kochanek K, Wlaschek M, Briviba K, Sies H. Singlet oxygen induces collagenase expression in human skin fibroblasts. FEBS Lett. 1993;331:304–6. doi: 10.1016/0014-5793(93)80357-Z.
    1. Oikarinen A. The aging of skin: chronoaging versus photoaging. Photodermatol Photoimmunol Photomed. 1990;7:3–4.
    1. Shuster S, Black MM, McVitie E. The influence of age and sex on skin thickness, skin collagen and density. Br J Dermatol. 1975;93:639–43. doi: 10.1111/j.1365-2133.1975.tb05113.x.
    1. Bernstein EF, Underhill CB, Hahn PJ, Brown DB, Uitto J. Chronic sun exposure alters both the content and distribution of dermal glycosaminoglycans. Br J Dermatol. 1996;135:255–62. doi: 10.1111/j.1365-2133.1996.tb01156.x.
    1. Elsner P, Maibach HI. Cosmeceuticals and Active Cosmetics: Drugs versus Cosmetics (2nd edn). Marcel Dekker: New York, 2005.
    1. Calasanti TM, Slevin KF, King N. Ageism and feminism: from ‘et cetera’ to center. NWSA J. 2006;18:13–30. doi: 10.2979/NWS.2006.18.1.13.
    1. Bayer K. Cosmetic surgery and cosmetics: redefining the appearance of age. Generations. 2005:13–8.
    1. Holstein MB, Minkler M. Self, society, and the “new gerontology”. Gerontologist. 2003;43:787–96. doi: 10.1093/geront/43.6.787.
    1. Mykytyn C. Anti-aging medicine: Predictions, moral obligations, and biomedical intervention. Anthropol Q. 2006;79:5–32. doi: 10.1353/anq.2006.0010.
    1. Wollina U, Payne CR. Aging well--the role of minimally invasive aesthetic dermatological procedures in women over 65. J Cosmet Dermatol. 2010;9:50–8. doi: 10.1111/j.1473-2165.2010.00475.x.
    1. Vedamurthy M. Antiaging therapies. Indian J Dermatol Venereol Leprol. 2006;72:183–6.
    1. Dierickx CC, Anderson RR. Visible light treatment of photoaging. Dermatol Ther. 2005;18:191–208. doi: 10.1111/j.1529-8019.2005.05019.x.
    1. Tabata N, O’Goshi K, Zhen YX, Kligman AM, Tagami H. Biophysical assessment of persistent effects of moisturizers after their daily applications: evaluation of corneotherapy. Dermatology. 2000;200:308–13. doi: 10.1159/000018393.
    1. Lübbe J. Evidence-based corneotherapy. Dermatology. 2000;200:285–9. doi: 10.1159/000018388.
    1. Varani J, Warner RL, Gharaee-Kermani M, Phan SH, Kang S, Chung JH, et al. Vitamin A antagonizes decreased cell growth and elevated collagen-degrading matrix metalloproteinases and stimulates collagen accumulation in naturally aged human skin. J Invest Dermatol. 2000;114:480–6. doi: 10.1046/j.1523-1747.2000.00902.x.
    1. Nusgens BV, Humbert P, Rougier A, Colige AC, Haftek M, Lambert CA, et al. Topically applied vitamin C enhances the mRNA level of collagens I and III, their processing enzymes and tissue inhibitor of matrix metalloproteinase 1 in the human dermis. J Invest Dermatol. 2001;116:853–9. doi: 10.1046/j.0022-202x.2001.01362.x.
    1. Kockaert M, Neumann M. Systemic and topical drugs for aging skin. J Drugs Dermatol. 2003;2:435–41.
    1. Margelin D, Medaisko C, Lombard D, Picard J, Fourtanier A. Hyaluronic acid and dermatan sulfate are selectively stimulated by retinoic acid in irradiated and nonirradiated hairless mouse skin. J Invest Dermatol. 1996;106:505–9. doi: 10.1111/1523-1747.ep12343819.
    1. Trautinger F. Mechanisms of photodamage of the skin and its functional consequences for skin ageing. Clin Exp Dermatol. 2001;26:573–7. doi: 10.1046/j.1365-2230.2001.00893.x.
    1. Berger MM. Can oxidative damage be treated nutritionally? Clin Nutr. 2005;24:172–83. doi: 10.1016/j.clnu.2004.10.003.
    1. Marini A. [Beauty from the inside. Does it really work?] Hautarzt. 2011;62:614–7. doi: 10.1007/s00105-011-2138-5.
    1. Fusco D, Colloca G, Lo Monaco MR, Cesari M. Effects of antioxidant supplementation on the aging process. Clin Interv Aging. 2007;2:377–87.
    1. Terada A, Yoshida M, Seko Y, Kobayashi T, Yoshida K, Nakada M, et al. Active oxygen species generation and cellular damage by additives of parenteral preparations: selenium and sulfhydryl compounds. Nutrition. 1999;15:651–5. doi: 10.1016/S0899-9007(99)00119-7.
    1. Lin FH, Lin JY, Gupta RD, Tournas JA, Burch JA, Selim MA, et al. Ferulic acid stabilizes a solution of vitamins C and E and doubles its photoprotection of skin. J Invest Dermatol. 2005;125:826–32. doi: 10.1111/j.0022-202X.2005.23768.x.
    1. Bissett DL, Miyamoto K, Sun P, Li J, Berge CA. Topical niacinamide reduces yellowing, wrinkling, red blotchiness, and hyperpigmented spots in aging facial skin. Int J Cosmet Sci. 2004;26:231–8. doi: 10.1111/j.1467-2494.2004.00228.x.
    1. Haftek M, Mac-Mary S, Le Bitoux MA, Creidi P, Seité S, Rougier A, et al. Clinical, biometric and structural evaluation of the long-term effects of a topical treatment with ascorbic acid and madecassoside in photoaged human skin. Exp Dermatol. 2008;17:946–52. doi: 10.1111/j.1600-0625.2008.00732.x.
    1. Kerscher M, Buntrock H. [Anti-aging creams. What really helps?] Hautarzt. 2011;62:607–13. doi: 10.1007/s00105-011-2137-6.
    1. Murray JC, Burch JA, Streilein RD, Iannacchione MA, Hall RP, Pinnell SR. A topical antioxidant solution containing vitamins C and E stabilized by ferulic acid provides protection for human skin against damage caused by ultraviolet irradiation. J Am Acad Dermatol. 2008;59:418–25. doi: 10.1016/j.jaad.2008.05.004.
    1. Draelos ZD. The latest cosmeceutical approaches for anti-aging. J Cosmet Dermatol. 2007;6:2–6. doi: 10.1111/j.1473-2165.2007.00313.x.
    1. Zhai H, Behnam S, Villarama CD, Arens-Corell M, Choi MJ, Maibach HI. Evaluation of the antioxidant capacity and preventive effects of a topical emulsion and its vehicle control on the skin response to UV exposure. Skin Pharmacol Physiol. 2005;18:288–93. doi: 10.1159/000088014.
    1. Elmets CA, Singh D, Tubesing K, Matsui M, Katiyar S, Mukhtar H. Cutaneous photoprotection from ultraviolet injury by green tea polyphenols. J Am Acad Dermatol. 2001;44:425–32. doi: 10.1067/mjd.2001.112919.
    1. Kafi R, Kwak HS, Schumacher WE, Cho S, Hanft VN, Hamilton TA, et al. Improvement of naturally aged skin with vitamin A (retinol) Arch Dermatol. 2007;143:606–12. doi: 10.1001/archderm.143.5.606.
    1. Varani J, Warner RL, Gharaee-Kermani M, Phan SH, Kang S, Chung JH, et al. Vitamin A antagonizes decreased cell growth and elevated collagen-degrading matrix metalloproteinases and stimulates collagen accumulation in naturally aged human skin. J Invest Dermatol. 2000;114:480–6. doi: 10.1046/j.1523-1747.2000.00902.x.
    1. Bhawan J. Short- and long-term histologic effects of topical tretinoin on photodamaged skin. Int J Dermatol. 1998;37:286–92. doi: 10.1046/j.1365-4362.1998.00433.x.
    1. Lupo MP, Cole AL. Cosmeceutical peptides. Dermatol Ther. 2007;20:343–9. doi: 10.1111/j.1529-8019.2007.00148.x.
    1. Nelson BR, Majmudar G, Griffiths CE, Gillard MO, Dixon AE, Tavakkol A, et al. Clinical improvement following dermabrasion of photoaged skin correlates with synthesis of collagen I. Arch Dermatol. 1994;130:1136–42. doi: 10.1001/archderm.1994.01690090060008.
    1. Ostler EL, Wallis CV, Aboalchamat B, Faragher RG. Telomerase and the cellular lifespan: implications of the aging process. J Pediatr Endocrinol Metab. 2000;13(Suppl 6):1467–76.
    1. Monheit GD, Chastain MA. Chemical peels. Facial Plast Surg Clin North Am. 2001;9:239–55, viii.
    1. Fischer TC, Perosino E, Poli F, Viera MS, Dreno B, Cosmetic Dermatology European Expert Group Chemical peels in aesthetic dermatology: an update 2009. J Eur Acad Dermatol Venereol. 2010;24:281–92. doi: 10.1111/j.1468-3083.2009.03409.x.
    1. Brown AM, Kaplan LM, Brown ME. Phenol-induced histological skin changes: hazards, technique, and uses. Br J Plast Surg. 1960;13:158–69. doi: 10.1016/S0007-1226(60)80032-X.
    1. Fartasch M, Teal J, Menon GK. Mode of action of glycolic acid on human stratum corneum: ultrastructural and functional evaluation of the epidermal barrier. Arch Dermatol Res. 1997;289:404–9. doi: 10.1007/s004030050212.
    1. Deprez P. Textbook of Chemical Peels. Superficial, Medium, and Deep Peels in Cosmetic Practice. Informa UK, London, 2007.
    1. Baker TJ, Gordon HL. The ablation of rhytides by chemical means; a preliminary report. J Fla Med Assoc. 1961;48:541.
    1. Behin F, Feuerstein SS, Marovitz WF. Comparative histological study of mini pig skin after chemical peel in an animal model after chemical peel and dermabrasion. Arch Otolaryngol. 1977;103:271. doi: 10.1001/archotol.1977.00780220065006.
    1. Vagotis FL, Brundage SR. Histologic study of dermabrasion and chemical peel in an animal model after pretreatment with Retin-A. Aesthetic Plast Surg. 1995;19:243–6. doi: 10.1007/BF00451097.
    1. Han SH, Kim HJ, Kim SY, Kim YC, Choi GS, Shin JH. Effects of chemical peeling in photoaged hairless mice. Int J Dermatol. 2011;50:1075–82. doi: 10.1111/j.1365-4632.2010.04712.x.
    1. Butler PE, Gonzalez S, Randolph MA, Kim J, Kollias N, Yaremchuk MJ. Quantitative and qualitative effects of chemical peeling on photo-aged skin: an experimental study. Plast Reconstr Surg. 2001;107:222–8. doi: 10.1097/00006534-200101000-00036.
    1. Nelson BR, Fader DJ, Gillard M, Majmudar G, Johnson TM. Pilot histologic and ultrastructural study of the effects of medium-depth chemical facial peels on dermal collagen in patients with actinically damaged skin. J Am Acad Dermatol. 1995;32:472–8. doi: 10.1016/0190-9622(95)90072-1.
    1. El-Domyati MB, Attia SK, Saleh FY, Ahmad HM, Uitto JJ. Trichloroacetic acid peeling versus dermabrasion: a histometric, immunohistochemical, and ultrastructural comparison. Dermatol Surg. 2004;30:179–88. doi: 10.1111/j.1524-4725.2004.30061.x.
    1. Sadick NS. Update on non-ablative light therapy for rejuvenation: a review. Lasers Surg Med. 2003;32:120–8. doi: 10.1002/lsm.10127.
    1. Hardaway CA, Ross EV. Nonablative laser skin remodeling. Dermatol Clin. 2002;20:97–111, ix. doi: 10.1016/S0733-8635(03)00049-4.
    1. Bjerring P, Christiansen K, Troilius A, Dierickx C. Facial photo rejuvenation using two different intense pulsed light (IPL) wavelength bands. Lasers Surg Med. 2004;34:120–6. doi: 10.1002/lsm.20000.
    1. Goldberg DJ. Full-face nonablative dermal remodeling with a 1320 nm Nd:YAG laser. Dermatol Surg. 2000;26:915–8. doi: 10.1046/j.1524-4725.2000.026010915.x.
    1. Goldberg DJ, Rogachefsky AS, Silapunt S. Non-ablative laser treatment of facial rhytides: a comparison of 1450-nm diode laser treatment with dynamic cooling as opposed to treatment with dynamic cooling alone. Lasers Surg Med. 2002;30:79–81. doi: 10.1002/lsm.10011.
    1. Fournier N, Dahan S, Barneon G, Rouvrais C, Diridollou S, Lagarde JM, et al. Nonablative remodeling: a 14-month clinical ultrasound imaging and profilometric evaluation of a 1540 nm Er:Glass laser. Dermatol Surg. 2002;28:926–31. doi: 10.1046/j.1524-4725.2002.02078.x.
    1. Bjerring P, Clement M, Heickendorff L, Egevist H, Kiernan M. Selective non-ablative wrinkle reduction by laser. J Cutan Laser Ther. 2000;2:9–15.
    1. Zelickson BD, Kilmer SL, Bernstein E, Chotzen VA, Dock J, Mehregan D, et al. Pulsed dye laser therapy for sun damaged skin. Lasers Surg Med. 1999;25:229–36. doi: 10.1002/(SICI)1096-9101(1999)25:3<229::AID-LSM7>;2-D.
    1. Goldberg D, Tan M, Dale Sarradet M, Gordon M. Nonablative dermal remodeling with a 585-nm, 350-microsec, flashlamp pulsed dye laser: clinical and ultrastructural analysis. Dermatol Surg. 2003;29:161–3, discussion 163-4. doi: 10.1046/j.1524-4725.2003.29040.x.
    1. Prieto VG, Sadick NS, Lloreta J, Nicholson J, Shea CR. Effects of intense pulsed light on sun-damaged human skin, routine, and ultrastructural analysis. Lasers Surg Med. 2002;30:82–5. doi: 10.1002/lsm.10042.
    1. Tanghetti E, Sherr E. Treatment of telangiectasia using the multi-pass technique with the extended pulse width, pulsed dye laser (Cynosure V-Star) J Cosmet Laser Ther. 2003;5:71–5. doi: 10.1080/14769170310001249.
    1. Alam M, Dover JS, Arndt KA. Treatment of facial telangiectasia with variable-pulse high-fluence pulsed-dye laser: comparison of efficacy with fluences immediately above and below the purpura threshold. Dermatol Surg. 2003;29:681–4, discussion 685. doi: 10.1046/j.1524-4725.2003.29181.x.
    1. Negishi K, Wakamatsu S, Kushikata N, Tezuka Y, Kotani Y, Shiba K. Full-face photorejuvenation of photodamaged skin by intense pulsed light with integrated contact cooling: initial experiences in Asian patients. Lasers Surg Med. 2002;30:298–305. doi: 10.1002/lsm.10036.
    1. Negishi K, Tezuka Y, Kushikata N, Wakamatsu S. Photorejuvenation for Asian skin by intense pulsed light. Dermatol Surg. 2001;27:627–31, discussion 632. doi: 10.1046/j.1524-4725.2001.01002.x.
    1. Omi T, Kawana S, Sato S, Honda M. Ultrastructural changes elicited by a non-ablative wrinkle reduction laser. Lasers Surg Med. 2003;32:46–9. doi: 10.1002/lsm.10119.
    1. Zelickson B, Kist D. Effect of pulsed dye laser and intense pulse light source in dermal extracellular matrix remodeling. Lasers Surg Med. 2000;S12:68.
    1. Hsu TS, Zelickson B, Dover JS, Kilmer S, Burns J, Hruza G, et al. Multicenter study of the safety and efficacy of a 585 nm pulsed-dye laser for the nonablative treatment of facial rhytides. Dermatol Surg. 2005;31:1–9.
    1. Moody BR, McCarthy JE, Hruza GJ. Collagen remodeling after 585-nm pulsed dye laser irradiation: an ultrasonographic analysis. Dermatol Surg. 2003;29:997–9, discussion 999-1000. doi: 10.1046/j.1524-4725.2003.29290.x.
    1. Bjerring P, Clement M, Heickendorff L, Lybecker H, Kiernan M. Dermal collagen production following irradiation by dye laser and broadband light source. J Cosmet Laser Ther. 2002;4:39–43. doi: 10.1080/147641702320602555.
    1. Dahiya R, Lam SM, Williams EF., 3rd A systematic histologic analysis of nonablative laser therapy in a porcine model using the pulsed dye laser. Arch Facial Plast Surg. 2003;5:218–23. doi: 10.1001/archfaci.5.3.218.
    1. Goldberg DJ, Cutler KB. Nonablative treatment of rhytids with intense pulsed light. Lasers Surg Med. 2000;26:196–200. doi: 10.1002/(SICI)1096-9101(2000)26:2<196::AID-LSM10>;2-9.
    1. Goldberg DJ. New collagen formation after dermal remodeling with an intense pulsed light source. J Cutan Laser Ther. 2000;2:59–61.
    1. Hernández-Pérez E, Ibiett EV. Gross and microscopic findings in patients submitted to nonablative full-face resurfacing using intense pulsed light: a preliminary study. Dermatol Surg. 2002;28:651–5. doi: 10.1046/j.1524-4725.2002.02010.x.
    1. Alster TS, Garg S. Treatment of facial rhytides with a high-energy pulsed carbon dioxide laser. Plast Reconstr Surg. 1996;98:791–4. doi: 10.1097/00006534-199610000-00005.
    1. Lowe NJ, Lask G, Griffin ME, Maxwell A, Lowe P, Quilada F. Skin resurfacing with the Ultrapulse carbon dioxide laser. Observations on 100 patients. Dermatol Surg. 1995;21:1025–9. doi: 10.1016/1076-0512(96)82352-1.
    1. Fitzpatrick RE, Goldman MP, Satur NM, Tope WD. Pulsed carbon dioxide laser resurfacing of photo-aged facial skin. Arch Dermatol. 1996;132:395–402. doi: 10.1001/archderm.1996.03890280047007.
    1. Teikemeier G, Goldberg DJ. Skin resurfacing with the erbium:YAG laser. Dermatol Surg. 1997;23:685–7. doi: 10.1016/S1076-0512(97)00179-9.
    1. Biesman BS. Fractional ablative skin resurfacing: complications. Lasers Surg Med. 2009;41:177–8. doi: 10.1002/lsm.20764.
    1. Manstein D, Herron GS, Sink RK, Tanner H, Anderson RR. Fractional photothermolysis: a new concept for cutaneous remodeling using microscopic patterns of thermal injury. Lasers Surg Med. 2004;34:426–38. doi: 10.1002/lsm.20048.
    1. Farkas JP, Richardson JA, Hoopman J, Brown SA, Kenkel JM. Micro-island damage with a nonablative 1540-nm Er:Glass fractional laser device in human skin. J Cosmet Dermatol. 2009;8:119–26. doi: 10.1111/j.1473-2165.2009.00441.x.
    1. Laubach HJ, Tannous Z, Anderson RR, Manstein D. Skin responses to fractional photothermolysis. Lasers Surg Med. 2006;38:142–9. doi: 10.1002/lsm.20254.
    1. Helbig D, Paasch U. Molecular changes during skin aging and wound healing after fractional ablative photothermolysis. Skin Res Technol. 2011;17:119–28. doi: 10.1111/j.1600-0846.2010.00477.x.
    1. Hantash BM, Bedi VP, Kapadia B, Rahman Z, Jiang K, Tanner H, et al. In vivo histological evaluation of a novel ablative fractional resurfacing device. Lasers Surg Med. 2007;39:96–107. doi: 10.1002/lsm.20468.
    1. Arany PR, Nayak RS, Hallikerimath S, Limaye AM, Kale AD, Kondaiah P. Activation of latent TGF-beta1 by low-power laser in vitro correlates with increased TGF-beta1 levels in laser-enhanced oral wound healing. Wound Repair Regen. 2007;15:866–74. doi: 10.1111/j.1524-475X.2007.00306.x.
    1. Souil E, Capon A, Mordon S, Dinh-Xuan AT, Polla BS, Bachelet M. Treatment with 815-nm diode laser induces long-lasting expression of 72-kDa heat shock protein in normal rat skin. Br J Dermatol. 2001;144:260–6. doi: 10.1046/j.1365-2133.2001.04010.x.
    1. Wilmink GJ, Opalenik SR, Beckham JT, Abraham AA, Nanney LB, Mahadevan-Jansen A, et al. Molecular imaging-assisted optimization of hsp70 expression during laser-induced thermal preconditioning for wound repair enhancement. J Invest Dermatol. 2009;129:205–16. doi: 10.1038/jid.2008.175.
    1. Ravanti L, Kähäri VM. Matrix metalloproteinases in wound repair (review) Int J Mol Med. 2000;6:391–407.
    1. Orringer JS, Kang S, Johnson TM, Karimipour DJ, Hamilton T, Hammerberg C, et al. Connective tissue remodeling induced by carbon dioxide laser resurfacing of photodamaged human skin. Arch Dermatol. 2004;140:1326–32. doi: 10.1001/archderm.140.11.1326.
    1. Raulin C, Greve B, Grema H. IPL technology: a review. Lasers Surg Med. 2003;32:78–87. doi: 10.1002/lsm.10145.
    1. Iorizzo M, De Padova MP, Tosti A. Biorejuvenation: theory and practice. Clin Dermatol. 2008;26:177–81. doi: 10.1016/j.clindermatol.2007.09.011.
    1. Rotunda AM, Kolodney MS. Mesotherapy and phosphatidylcholine injections: historical clarification and review. Dermatol Surg. 2006;32:465–80. doi: 10.1111/j.1524-4725.2006.32100.x.
    1. Caruso MK, Roberts AT, Bissoon L, Self KS, Guillot TS, Greenway FL. An evaluation of mesotherapy solutions for inducing lipolysis and treating cellulite. J Plast Reconstr Aesthet Surg. 2008;61:1321–4. doi: 10.1016/j.bjps.2007.03.039.
    1. Matarasso A, Pfeifer TM, Plastic Surgery Educational Foundation DATA Committee Mesotherapy for body contouring. Plast Reconstr Surg. 2005;115:1420–4. doi: 10.1097/01.PRS.0000162227.94032.ED.
    1. Rotunda AM, Avram MM, Avram AS. Cellulite: Is there a role for injectables? J Cosmet Laser Ther. 2005;7:147–54. doi: 10.1080/14764170500430234.
    1. Lacarrubba F, Tedeschi A, Nardone B, Micali G. Mesotherapy for skin rejuvenation: assessment of the subepidermal low-echogenic band by ultrasound evaluation with cross-sectional B-mode scanning. Dermatol Ther. 2008;21(Suppl 3):S1–5. doi: 10.1111/j.1529-8019.2008.00234.x.
    1. Jager C, Brenner C, Habicht J, Wallic R. Bioactive reagents used in mesotherapy for skin rejuvenation in vivo induce diverse physiological processes in human skin fibroblasts in vitro – a pilot study. Exp Dermatol. 2011;21:70–80.
    1. Amin SP, Phelps RG, Goldberg DJ. Mesotherapy for facial skin rejuvenation: a clinical, histologic, and electron microscopic evaluation. Dermatol Surg. 2006;32:1467–72. doi: 10.1111/j.1524-4725.2006.32353.x.
    1. Atiyeh BS, Ibrahim AE, Dibo SA. Aesthetic Plast Surg 2008: 32: 842–849. 12 Brown S A. Aesthet Surg J. 2006;26:95–8.
    1. Eppley BL, Dadvand B. Injectable soft-tissue fillers: clinical overview. Plast Reconstr Surg. 2006;118:98e–106e. doi: 10.1097/01.prs.0000232436.91409.30.
    1. Haneke E. Skin rejuvenation without a scalpel. I. Fillers. J Cosmet Dermatol. 2006;5:157–67. doi: 10.1111/j.1473-2165.2006.00243.x.
    1. Homicz MR, Watson D. Review of injectable materials for soft tissue augmentation. Facial Plast Surg. 2004;20:21–9. doi: 10.1055/s-2004-822955.
    1. Kanchwala SK, Holloway L, Bucky LP. Reliable soft tissue augmentation: a clinical comparison of injectable soft-tissue fillers for facial-volume augmentation. Ann Plast Surg. 2005;55:30–5, discussion 35. doi: 10.1097/01.sap.0000168292.69753.73.
    1. Klein AW. Techniques for soft tissue augmentation: an ‘a to z’. Am J Clin Dermatol. 2006;7:107–20. doi: 10.2165/00128071-200607020-00004.
    1. Laurent TC, Fraser JR. Hyaluronan. FASEB J. 1992;6:2397–404.
    1. Tzellos TG, Klagas I, Vahtsevanos K, Triaridis S, Printza A, Kyrgidis A, et al. Extrinsic ageing in the human skin is associated with alterations in the expression of hyaluronic acid and its metabolizing enzymes. Exp Dermatol. 2009;18:1028–35. doi: 10.1111/j.1600-0625.2009.00889.x.
    1. Alberts B, Johnson A, Lewis J, et al., eds. 2002. The molecular biology of the cell. Cell junctions, cell adhesion, and the extracellular matrix. 1065. New York: Garland Science.
    1. Sherman L, Sleeman J, Herrlich P, Ponta H. Hyaluronate receptors: key players in growth, differentiation, migration and tumor progression. Curr Opin Cell Biol. 1994;6:726–33. doi: 10.1016/0955-0674(94)90100-7.
    1. Turley EA. Hyaluronan and cell locomotion. Cancer Metastasis Rev. 1992;11:21–30. doi: 10.1007/BF00047600.
    1. Papakonstantinou E, Karakiulakis G, Eickelberg O, Perruchoud AP, Block L-H, Roth M. A 340 kDa hyaluronic acid secreted by human vascular smooth muscle cells regulates their proliferation and migration. Glycobiology. 1998;8:821–30. doi: 10.1093/glycob/8.8.821.
    1. Tammi MI, Day AJ, Turley EA. Hyaluronan and homeostasis: a balancing act. J Biol Chem. 2002;277:4581–4. doi: 10.1074/jbc.R100037200.
    1. Fligiel SE, Varani J, Datta SC, Kang S, Fisher GJ, Voorhees JJ. Collagen degradation in aged/photodamaged skin in vivo and after exposure to matrix metalloproteinase-1 in vitro. J Invest Dermatol. 2003;120:842–8. doi: 10.1046/j.1523-1747.2003.12148.x.
    1. Kuroda K, Shinkai H. Gene expression of types I and III collagen, decorin, matrix metalloproteinases and tissue inhibitors of metalloproteinases in skin fibroblasts from patients with systemic sclerosis. Arch Dermatol Res. 1997;289:567–72. doi: 10.1007/s004030050241.
    1. Uitto J, Bernstein EF. Molecular mechanisms of cutaneous aging: connective tissue alterations in the dermis. J Investig Dermatol Symp Proc. 1998;3:41–4.
    1. Yoneda M, Shimizu S, Nishi Y, Yamagata M, Suzuki S, Kimata K. Hyaluronic acid-dependent change in the extracellular matrix of mouse dermal fibroblasts that is conducive to cell proliferation. J Cell Sci. 1988;90:275–86.
    1. Gao F, Liu Y, He Y, Yang C, Wang Y, Shi X, et al. Hyaluronan oligosaccharides promote excisional wound healing through enhanced angiogenesis. Matrix Biol. 2010;29:107–16. doi: 10.1016/j.matbio.2009.11.002.
    1. Jiang D, Liang J, Noble PW. Hyaluronan in tissue injury and repair. Annu Rev Cell Dev Biol. 2007;23:435–61. doi: 10.1146/annurev.cellbio.23.090506.123337.
    1. Fink RM, Lengfelder E. Hyaluronic acid degradation by ascorbic acid and influence of iron. Free Radic Res Commun. 1987;3:85–92. doi: 10.3109/10715768709069773.
    1. Carruthers A, Carruthers J. Non-animal-based hyaluronic acid fillers: scientific and technical considerations. Plast Reconstr Surg. 2007;120(Suppl):33S–40S. doi: 10.1097/01.prs.0000248808.75700.5f.
    1. Balazs EA, Bland PA, Denlinger JL, Goldman AI, Larsen NE, Leshchiner EA, et al. Matrix engineering. Blood Coagul Fibrinolysis. 1991;2:173–8. doi: 10.1097/00001721-199102000-00026.
    1. Andre P. New trends in face rejuvenation by hyaluronic acid injections. J Cosmet Dermatol. 2008;7:251–8. doi: 10.1111/j.1473-2165.2008.00402.x.
    1. Eppley BL, Dadvand B. Injectable soft-tissue fillers: clinical overview. Plast Reconstr Surg. 2006;118:98e–106e. doi: 10.1097/01.prs.0000232436.91409.30.
    1. Gold MH. Use of hyaluronic acid fillers for the treatment of the aging face. Clin Interv Aging. 2007;2:369–76.
    1. Robinson JK, Hanke CW, Sengelmann RD, Siegel DM. Surgery of the skin. Philadelphia: Elsevier Mosby, 2005.
    1. Alam M, Gladstone H, Kramer EM, Murphy JP, Jr., Nouri K, Neuhaus IM, et al. American Society for Dermatologic Surgery ASDS guidelines of care: injectable fillers. Dermatol Surg. 2008;34(Suppl 1):S115–48. doi: 10.1111/j.1524-4725.2008.34253.x.
    1. Lizzul PF, Narurkar VA. The role of calcium hydroxylapatite (Radiesse) in nonsurgical aesthetic rejuvenation. J Drugs Dermatol. 2010;9:446–50.
    1. Goldberg DJ. Breakthroughs in US dermal fillers for facial soft-tissue augmentation. J Cosmet Laser Ther. 2009;11:240–7. doi: 10.3109/14764170903341731.
    1. Ghersetich I, Lotti T, Campanile G, Grappone C, Dini G. Hyaluronic acid in cutaneous intrinsic aging. Int J Dermatol. 1994;33:119–22. doi: 10.1111/j.1365-4362.1994.tb01540.x.
    1. Graivier MH, Bass LS, Busso M, Jasin ME, Narins RS, Tzikas TL. Calcium hydroxylapatite (Radiesse) for correction of the mid- and lower face: consensus recommendations. Plast Reconstr Surg. 2007;120(Suppl):55S–66S. doi: 10.1097/01.prs.0000285109.34527.b9.
    1. Tzikas TL. A 52-month summary of results using calcium hydroxylapatite for facial soft tissue augmentation. Dermatol Surg. 2008;34(Suppl 1):S9–15. doi: 10.1111/j.1524-4725.2008.34237.x.
    1. Burgess CM, Lowe NJ. NewFill for skin augmentation: a new filler or failure? Dermatol Surg. 2006;32:1530–2, author reply 1532. doi: 10.1111/j.1524-4725.2006.32369.x.
    1. Mest D. Experience with injectable poly-L-lactic acid in clinicalpractice. Cosmetic Dermatol. 2005;18:5–8.
    1. Burgess CM, Quiroga RM. Assessment of the safety and efficacy of poly-L-lactic acid for the treatment of HIV-associated facial lipoatrophy. J Am Acad Dermatol. 2005;52:233–9. doi: 10.1016/j.jaad.2004.08.056.
    1. Sturm LP, Cooter RD, Mutimer KL, Graham JC, Maddern GJ. A systematic review of dermal fillers for age-related lines and wrinkles. ANZ J Surg. 2011;81:9–17. doi: 10.1111/j.1445-2197.2010.05351.x.
    1. Zimmermann R, Jakubietz R, Jakubietz M, Strasser E, Schlegel A, Wiltfang J, et al. Different preparation methods to obtain platelet components as a source of growth factors for local application. Transfusion. 2001;41:1217–24. doi: 10.1046/j.1537-2995.2001.41101217.x.
    1. Marx RE. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg. 2004;62:489–96. doi: 10.1016/j.joms.2003.12.003.
    1. Freymiller EG. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg. 2004;62:1046–, author reply 1047-8. doi: 10.1016/j.joms.2004.05.205.
    1. Wrotniak M, Bielecki T, Gaździk TS. Current opinion about using the platelet-rich gel in orthopaedics and trauma surgery. Ortop Traumatol Rehabil. 2007;9:227–38.
    1. Kim DH, Je YJ, Kim CD, Lee YH, Seo YJ, Lee JH, et al. Can Platelet-rich Plasma Be Used for Skin Rejuvenation? Evaluation of Effects of Platelet-rich Plasma on Human Dermal Fibroblast. Ann Dermatol. 2011;23:424–31.
    1. Krasna M, Domanovic D, Tomsic A, Svajger U, Jeras M. Platelet gel stimulates proliferation of human dermal fibroblasts in vitro. Acta Dermatovenerol Alp Panonica Adriat. 2007;16:105–10.
    1. Lucarelli E, Beccheroni A, Donati D, Sangiorgi L, Cenacchi A, Del Vento AM, et al. Platelet-derived growth factors enhance proliferation of human stromal stem cells. Biomaterials. 2003;24:3095–100. doi: 10.1016/S0142-9612(03)00114-5.
    1. Kanno T, Takahashi T, Tsujisawa T, Ariyoshi W, Nishihara T. Platelet-rich plasma enhances human osteoblast-like cell proliferation and differentiation. J Oral Maxillofac Surg. 2005;63:362–9. doi: 10.1016/j.joms.2004.07.016.
    1. Dessy LA, Mazzocchi M, Rubino C, Mazzarello V, Spissu N, Scuderi N. An objective assessment of botulinum toxin A effect on superficial skin texture. Ann Plast Surg. 2007;58:469–73. doi: 10.1097/01.sap.0000244968.16977.1f.
    1. Cheng CM. Cosmetic use of botulinum toxin type A in the elderly. Clin Interv Aging. 2007;2:81–3. doi: 10.2147/ciia.2007.2.1.81.
    1. Rzany B, Dill-Müller D, Grablowitz D, Heckmann M, Caird D, German-Austrian Retrospective Study Group Repeated botulinum toxin A injections for the treatment of lines in the upper face: a retrospective study of 4,103 treatments in 945 patients. Dermatol Surg. 2007;33(1 Spec No.):S18–25. doi: 10.1111/j.1524-4725.2006.32327.x.
    1. Böni R, Kreyden OP, Burg G. Revival of the use of botulinum toxin: application in dermatology. Dermatology. 2000;200:287–91. doi: 10.1159/000018389.
    1. Coffield JA, Considine RB, Simpson LL. The site and mechanism of action of botulinum neurotoxin; in Jankovic J, Hallett M (eds): Therapy with Botulinum Toxin. New York, Dekker, 1994, pp 3–14.
    1. Coleman WP, Hanke CW, Alt TH. Cosmetic Surgery of the Skin, 2nd edn. St Louis, Missouri: Mosby Year Book Inc., 1997: 231-235.
    1. Garcia A, Fulton JE., Jr. Cosmetic denervation of the muscles of facial expression with botulinum toxin. A dose-response study. Dermatol Surg. 1996;22:39–43. doi: 10.1016/1076-0512(95)00464-5.
    1. Carruthers A, Kiene K, Carruthers J. Botulinum A exotoxin use in clinical dermatology. J Am Acad Dermatol. 1996;34:788–97. doi: 10.1016/S0190-9622(96)90016-X.
    1. Guyuron B, Huddleston SW. Aesthetic indications for botulinum toxin injection. Plast Reconstr Surg. 1994;93:913–8. doi: 10.1097/00006534-199404001-00003.
    1. Brooks GF, Butel JS, Ornston LN. Jawetz, Melnick and Adelbergs Medical Microbiology, 20th edn. Connecticut: Appleton and Lange, 1995: 174±176.
    1. Aoki RK. Immunologic and other properties of therapeutic botulinum toxin serotypes. In: BrinMF, Hallett M, Jankovic J, eds. Scientific and Therapeutic Aspects of Botulinum Toxin. Philadelphia, PA: Lippincott Williams & Wilkins; 2002.
    1. Becker-Wegerich P, Rauch L, Ruzicka T. Botulinum toxin A in the therapy of mimic facial lines. Clin Exp Dermatol. 2001;26:619–30. doi: 10.1046/j.1365-2230.2001.00901.x.
    1. Ganong WF. Review of Medical Physiology, 16th edn. East Norwalk, Connecticut: Appleton and Lange, 1993: 99±102.
    1. de Paiva A, Meunier FA, Molgó J, Aoki KR, Dolly JO. Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals. Proc Natl Acad Sci U S A. 1999;96:3200–5. doi: 10.1073/pnas.96.6.3200.
    1. Product Information Package Insert. (71390US12J). Irvine, CA: Allergan, Inc.; 2002.
    1. Hatheway CG. Immunology of Botulinum Toxin. New York: Marcel-Dekker; 1993.
    1. Huang W, Foster JA, Rogachefsky AS. Pharmacology of botulinum toxin. J Am Acad Dermatol. 2000;43:249–59. doi: 10.1067/mjd.2000.105567.
    1. Rzany B, Ascher B, Monheit GD. Treatment of glabellar lines with botulinum toxin type A (Speywood Unit): a clinical overview. J Eur Acad Dermatol Venereol. 2010;24(Suppl 1):1–14. doi: 10.1111/j.1468-3083.2009.03475.x.
    1. Botox (Package Insert). Allergan, Inc.
    1. Carruthers J, Fagien S, Matarasso SL. the Botox Consensus Group. Botulinum toxin and facial aesthetics. Plast Reconstr Surg. 2004;114:1S–22S. doi: 10.1097/01.PRS.0000144795.76040.D3.
    1. Shetty MK, IADVL Dermatosurgery Task Force Guidelines on the use of botulinum toxin type A. Indian J Dermatol Venereol Leprol. 2008;74(Suppl):S13–22.
    1. Sommer B, Sattler G. Botulinumtoxin in der aÈsthetischen Medizin. Berlin; Blackwell Vissenschafts-Verlag, 2001.
    1. Carruthers J, Carruthers A. Cosmetic use of botulinum A exotoxin. In: Advances in Dermatology (Dzubow L, ed.) 1996: 280-303.
    1. Lange DJ, Rubin M, Greene PE, Kang UJ, Moskowitz CB, Brin MF, et al. Distant effects of locally injected botulinum toxin: a double-blind study of single fiber EMG changes. Muscle Nerve. 1991;14:672–5. doi: 10.1002/mus.880140711.
    1. Goschel H, et al. Botulinum toxin therapy, neutralizing and non-neutralizing antibodies. Exp Neurol. 1997;147:96. doi: 10.1006/exnr.1997.6580.
    1. Blitzer A, Binder WJ, Boyd JB, Carruthers A. Management of Facial Lines and Wrinkles. Philadelphia, PA: Lippincott Williams & Wilkins; 2000.
    1. Matarasso A, Deva AK, American Society of Plastic Surgeons DATA Committee Botulinum toxin. Plast Reconstr Surg. 2002;109:1191–7. doi: 10.1097/00006534-200203000-00066.
    1. Fagien S. Botox for the treatment of dynamic and hyperkinetic facial lines and furrows: adjunctive use in facial aesthetic surgery. Plast Reconstr Surg. 1999;103:701–13. doi: 10.1097/00006534-199902000-00055.
    1. Hertoghe T. The “multiple hormone deficiency” theory of aging: is human senescence caused mainly by multiple hormone deficiencies? Ann N Y Acad Sci. 2005;1057:448–65. doi: 10.1196/annals.1322.035.
    1. Cranney A, Papaioannou A, Zytaruk N, Hanley D, Adachi J, Goltzman D, et al. Clinical Guidelines Committee of Osteoporosis Canada Parathyroid hormone for the treatment of osteoporosis: a systematic review. CMAJ. 2006;175:52–9. doi: 10.1503/cmaj.050929.
    1. Vitetta L, Anton B. Lifestyle and nutrition, caloric restriction, mitochondrial health and hormones: scientific interventions for anti-aging. Clin Interv Aging. 2007;2:537–43.
    1. Heutling D, Lehnert H. [Hormone therapy and anti-aging: is there an indication?] Internist (Berl) 2008;49:570–80, 572-6, 578-9. doi: 10.1007/s00108-008-2110-3.
    1. Morales AJ, Nolan JJ, Nelson JC, Yen SS. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab. 1994;78:1360–7. doi: 10.1210/jc.78.6.1360.
    1. Baulieu EE, Thomas G, Legrain S, Lahlou N, Roger M, Debuire B, et al. Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue. Proc Natl Acad Sci U S A. 2000;97:4279–84. doi: 10.1073/pnas.97.8.4279.
    1. Jankowski CM, Gozansky WS, Schwartz RS, Dahl DJ, Kittelson JM, Scott SM, et al. Effects of dehydroepiandrosterone replacement therapy on bone mineral density in older adults: a randomized, controlled trial. J Clin Endocrinol Metab. 2006;91:2986–93. doi: 10.1210/jc.2005-2484.
    1. Nair KS, Rizza RA, O’Brien P, Dhatariya K, Short KR, Nehra A, et al. DHEA in elderly women and DHEA or testosterone in elderly men. N Engl J Med. 2006;355:1647–59. doi: 10.1056/NEJMoa054629.
    1. Wetterberg L, Bergiannaki JD, Paparrigopoulos T, von Knorring L, Eberhard G, Bratlid T, et al. Normative melatonin excretion: a multinational study. Psychoneuroendocrinology. 1999;24:209–26. doi: 10.1016/S0306-4530(98)00076-6.
    1. Roth GS, Lesnikov V, Lesnikov M, Ingram DK, Lane MA. Dietary caloric restriction prevents the age-related decline in plasma melatonin levels of rhesus monkeys. J Clin Endocrinol Metab. 2001;86:3292–5. doi: 10.1210/jc.86.7.3292.
    1. Ferrari E, Cravello L, Falvo F, Barili L, Solerte SB, Fioravanti M, et al. Neuroendocrine features in extreme longevity. Exp Gerontol. 2008;43:88–94. doi: 10.1016/j.exger.2007.06.010.
    1. Blask DE, Dauchy RT, Sauer LA. Putting cancer to sleep at night: the neuroendocrine/circadian melatonin signal. Endocrine. 2005;27:179–88. doi: 10.1385/ENDO:27:2:179.
    1. Heutling D, Lehnert H. [Hormone therapy and menopause] Dtsch Med Wochenschr. 2005;130:829–34. doi: 10.1055/s-2005-865097.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe